Bolt Biotherapeutics Inc (BOLT)
0.76
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.7567
0.00 (0.00%)
After-Hours: 20:00
Bolt Biotherapeutics Total Liabilities (Quarterly): 38.73M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 38.73M |
| December 31, 2023 | 47.04M |
| September 30, 2023 | 47.10M |
| June 30, 2023 | 48.56M |
| March 31, 2023 | 48.50M |
| December 31, 2022 | 56.30M |
| September 30, 2022 | 57.06M |
| June 30, 2022 | 52.27M |
| Date | Value |
|---|---|
| March 31, 2022 | 54.40M |
| December 31, 2021 | 57.60M |
| September 30, 2021 | 58.64M |
| June 30, 2021 | 51.18M |
| March 31, 2021 | 21.39M |
| December 31, 2020 | 151.49M |
| September 30, 2020 | 136.32M |
| December 31, 2019 | 94.29M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.39M
Minimum
Mar 2021
151.49M
Maximum
Dec 2020
63.80M
Average
53.33M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.89M |
| Shareholders Equity (Quarterly) | 104.16M |
| Current Ratio | 5.684 |